Cell Res.:NLRC5在抗感染免疫研究中起关键作用

2012-05-19 中科院 中科院

李斯特菌(L. monocytogenes)扫描电子显微图片,图片来自维基共享资源。 真核生物的天然免疫是抵抗外界病原体入侵的第一道防线。天然免疫主要是通过模式识别受体来识别病毒或细菌等外来病原体。Nod样受体(NLR)是近年来研究发现的识别胞内菌的模式受体。NLRC5作为Nod样受体家族中最大的一个成员,其生理学功能一直不清楚。 4月10号,Cell Research杂志在线发表中科院上海生


李斯特菌(L. monocytogenes)扫描电子显微图片,图片来自维基共享资源。

真核生物的天然免疫是抵抗外界病原体入侵的第一道防线。天然免疫主要是通过模式识别受体来识别病毒或细菌等外来病原体。Nod样受体(NLR)是近年来研究发现的识别胞内菌的模式受体。NLRC5作为Nod样受体家族中最大的一个成员,其生理学功能一直不清楚。

4月10号,Cell Research杂志在线发表中科院上海生命科学研究院/上海交通大学医学院健康科学研究所钱友存研究组关于NLRC5在抗胞内菌感染过程中的作用研究 (NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens)。该工作主要由博士生姚依昆和王亚龙在钱友存研究员的指导下完成。该论文首次利用NLRC5基因敲除小鼠研究发现NLRC5在宿主抵抗胞内菌感染方面发挥重要作用。NLRC5通过调控I类主要组织相容性复合体(MHC class I)的转录表达,进而影响胞内病原菌(李斯特菌,L. monocytogenes)特异性CD8+ T细胞的激活和增殖,从而有效清除病原菌。该研究阐明了宿主抗胞内菌感染的新机制,为感染性疾病的预防与治疗提供了重要的理论基础。

该课题获得国家自然科学基金委、国家科技部、中国科学院和上海市科委等经费资助。

doi:10.1038/cr.2012.56
PMC:
PMID:

NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens

Yikun Yao, Yalong Wang, Fuxiang Chen, Yin Huang, Shu Zhu, Qibin Leng, Hongyan Wang, Yufang Shi and Youcun Qian

NOD-like receptors (NLRs) are a family of intracellular proteins that play critical roles in innate immunity against microbial infection. NLRC5, the largest member of the NLR family, has recently attracted much attention. However, in vitro studies have reported inconsistent results about the roles of NLRC5 in host defense and in regulating immune signaling pathways. The in vivo function of NLRC5 remains unknown. Here, we report that NLRC5 is a critical regulator of host defense against intracellular pathogens in vivo. NLRC5 was specifically required for the expression of genes involved in MHC class I antigen presentation. NLRC5-deficient mice showed a profound defect in the expression of MHC class I genes and a concomitant failure to activate L. monocytogenes-specific CD8+ T cell responses, including activation, proliferation and cytotoxicity, and the mutant mice were more susceptible to the pathogen infection. NLRP3-mediated inflammasome activation was also partially impaired in NLRC5-deficient mice. However, NLRC5 was dispensable for pathogen-induced expression of NF-κB-dependent pro-inflammatory genes as well as type I interferon genes. Thus, NLRC5 critically regulates MHC class I antigen presentation to control intracellular pathogen infection.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1868507, encodeId=6e28186850e59, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Aug 30 23:15:00 CST 2012, time=2012-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958738, encodeId=f2a71958e3868, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Oct 22 23:15:00 CST 2012, time=2012-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793211, encodeId=efb21e93211f3, content=<a href='/topic/show?id=3c7315338cb' target=_blank style='color:#2F92EE;'>#Res.:#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15338, encryptionId=3c7315338cb, topicName=Res.:)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Mon Sep 17 22:15:00 CST 2012, time=2012-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407722, encodeId=1807140e72231, content=<a href='/topic/show?id=a22412862b3' target=_blank style='color:#2F92EE;'>#NLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12862, encryptionId=a22412862b3, topicName=NLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cd32710930, createdName=yuandd, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1868507, encodeId=6e28186850e59, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Aug 30 23:15:00 CST 2012, time=2012-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958738, encodeId=f2a71958e3868, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Oct 22 23:15:00 CST 2012, time=2012-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793211, encodeId=efb21e93211f3, content=<a href='/topic/show?id=3c7315338cb' target=_blank style='color:#2F92EE;'>#Res.:#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15338, encryptionId=3c7315338cb, topicName=Res.:)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Mon Sep 17 22:15:00 CST 2012, time=2012-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407722, encodeId=1807140e72231, content=<a href='/topic/show?id=a22412862b3' target=_blank style='color:#2F92EE;'>#NLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12862, encryptionId=a22412862b3, topicName=NLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cd32710930, createdName=yuandd, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
    2012-10-22 维他命
  3. [GetPortalCommentsPageByObjectIdResponse(id=1868507, encodeId=6e28186850e59, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Aug 30 23:15:00 CST 2012, time=2012-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958738, encodeId=f2a71958e3868, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Oct 22 23:15:00 CST 2012, time=2012-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793211, encodeId=efb21e93211f3, content=<a href='/topic/show?id=3c7315338cb' target=_blank style='color:#2F92EE;'>#Res.:#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15338, encryptionId=3c7315338cb, topicName=Res.:)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Mon Sep 17 22:15:00 CST 2012, time=2012-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407722, encodeId=1807140e72231, content=<a href='/topic/show?id=a22412862b3' target=_blank style='color:#2F92EE;'>#NLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12862, encryptionId=a22412862b3, topicName=NLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cd32710930, createdName=yuandd, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1868507, encodeId=6e28186850e59, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Aug 30 23:15:00 CST 2012, time=2012-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958738, encodeId=f2a71958e3868, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Oct 22 23:15:00 CST 2012, time=2012-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793211, encodeId=efb21e93211f3, content=<a href='/topic/show?id=3c7315338cb' target=_blank style='color:#2F92EE;'>#Res.:#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15338, encryptionId=3c7315338cb, topicName=Res.:)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Mon Sep 17 22:15:00 CST 2012, time=2012-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407722, encodeId=1807140e72231, content=<a href='/topic/show?id=a22412862b3' target=_blank style='color:#2F92EE;'>#NLR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12862, encryptionId=a22412862b3, topicName=NLR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cd32710930, createdName=yuandd, createdTime=Mon May 21 14:15:00 CST 2012, time=2012-05-21, status=1, ipAttribution=)]
    2012-05-21 yuandd

相关资讯

J. Immunol:日开发新方法可判断多发性硬化症疗效

近日,日本大阪大学和理化学研究所的研究小组在新一期《免疫学期刊》(The Journal of Immunology)上报告说,他们开发出一种血液检测方法,能够提前判断常用治疗药物培他干扰素对多发性硬化症患者是否有效。 多发性硬化症是一种中枢神经系统疾病,患者自身免疫细胞会错误攻击神经元髓鞘,造成患者出现视觉障碍、肌肉无力等症状。通常对多发性硬化症患者都采用注射培他干扰素进行治疗。&nb

Lancet:免疫接种可减少麻疹致死病例

4月24日,世界卫生组织与美国疾病控制和预防中心、联合国儿童基金会联合宣布一项旨在消除麻疹致死病例以及先天性风疹的全球计划。 最新一期英国《柳叶刀》(Lancet)杂志刊登报告称,免疫接种可减少麻疹致死病例。该研究显示,随着免疫接种的不断推广,全球因麻疹致死的人数从2000年的约53.53万下降到了2010年的13.93万,减少了74%。 这一全球计划希望通过五大措施实现以下目标:2015年将

JAMA:短信提醒可提高低收入儿童和青少年的流感疫苗接种率

据4月25日刊《美国医学会杂志》上的一项研究披露,与常规的医疗方式相比,一种通过给家长发送与教育有关的讯息短信的干预方法可在一个按照惯例难以联系到的、低收入的、城市少数族裔的儿童及青少年人群中增加流感疫苗接种的覆盖率,尽管总体的覆盖率仍然低下。 纽约市哥伦比亚大学的Melissa S. Stockwell, M.D., M.P.H.及其同事评估了以低收入、城市中的家长为目标的,宣传在儿童和青少年

Immuni:美阐明朗格汉斯细胞维持免疫自稳的机制

日前,美研究人员在线发表了题为《Human Epidermal Langerhans Cells Maintain Immune Homeostasis in Skin by Activating Skin Resident Regulatory T Cells》研究论文,阐明了朗格汉斯细胞是如何维持皮肤组织的免疫自稳。该研究论文发表在国际期刊Immunity上。 正常成年人的皮肤中常驻着100

PNAS:邵峰等肺炎军团菌逃避宿主AIM2炎症小体天然免疫研究获进展

近日,国际著名杂志PNAS在线刊登了北京生命科学研究所邵峰博士实验室的最新研究成果“Preventing bacterial DNA release and absent in melanoma 2 inflammasome activation by a Legionella effector functioning in membrane trafficking,”,该篇文章首次报道了肺炎军团

J Immun:过度卫生的生活方式或影响新生儿免疫系统的发育

MedSci评注:     近来一系列研究均表明,在新生儿免疫建立期(一般认为在出生后6个月左右),让免疫系统“适应”环境,训练免疫系统接触环境中不良因素,从而产生免疫耐受,减少今后的过敏反应。这些环境中的因素包括土壤中的微生素群落,空气土壤中的真菌,花粉,尘螨等,一旦早期建立起对这些物质的免疫耐受,可以防止青少年,甚至成年的众多自身免疫性疾病,过敏性疾病。因此,中